Literature DB >> 10713291

Intracerebroventricular insulin enhances memory in a passive-avoidance task.

C R Park1, R J Seeley, S Craft, S C Woods.   

Abstract

Previous studies have indicated a possible enhancing effect of hyperinsulinemia on certain cognitive tasks in human subjects. Further, brain areas important in these tasks have high concentrations of insulin receptors, suggesting that insulin might modulate memory by activity at specific central sites. Extending this observation to the laboratory rat would provide a convenient model system for determining factors important for this possible cognitive effect. The present experiment determined whether intracerebroventricular administration of insulin improves memory formation in rats. Long-Evans rats were trained on a step-through passive-avoidance task, in which they were either shocked or not after entering a darkened compartment. After training, the animals received an intracerebroventricular injection of 4 mU insulin, heat-deactivated insulin or saline vehicle. After 24 h, the animals were tested for retention of the task. Rats receiving insulin after being shocked had an increased latency to enter the dark compartment, compared to those rats that had received saline or heat-deactivated insulin after shock. This difference is consistent with an enhanced memory for the negative consequences of entering.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713291     DOI: 10.1016/s0031-9384(99)00220-6

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  109 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Insulin signaling plays a dual role in Caenorhabditis elegans memory acquisition and memory retrieval.

Authors:  Chia Hsun Anthony Lin; Masahiro Tomioka; Schreiber Pereira; Laurie Sellings; Yuichi Iino; Derek van der Kooy
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 3.  Cognitive and neuronal systems underlying obesity.

Authors:  Scott E Kanoski
Journal:  Physiol Behav       Date:  2012-01-12

4.  Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.

Authors:  Michael Gold; Claire Alderton; Marina Zvartau-Hind; Sally Egginton; Ann M Saunders; Michael Irizarry; Suzanne Craft; Gary Landreth; Ulla Linnamägi; Sharon Sawchak
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-21       Impact factor: 2.959

Review 5.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

Review 6.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

7.  Insulin promotes neuronal survival via the alternatively spliced protein kinase CδII isoform.

Authors:  André Apostolatos; Shijie Song; Sandra Acosta; Mishka Peart; James E Watson; Paula Bickford; Denise R Cooper; Niketa A Patel
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

8.  Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model.

Authors:  Ahmet Turan Isik; Turgay Celik; Gokhan Ulusoy; Onder Ongoru; Birsen Elibol; Huseyin Doruk; Ergun Bozoglu; Hakan Kayir; Mehmet Refik Mas; Serif Akman
Journal:  Age (Dordr)       Date:  2008-10-08

9.  Diabetes and the elderly brain: sweet memories?

Authors:  Katherine Samaras; Perminder S Sachdev
Journal:  Ther Adv Endocrinol Metab       Date:  2012-12       Impact factor: 3.565

10.  The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid.

Authors:  Han-Kyu Lee; Pravir Kumar; Qinghao Fu; Kenneth M Rosen; Henry W Querfurth
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.